Dec 14, 2023
Rapid Commercialization Partners (RCP), a leader in the commercial acceleration of advanced biotechnology therapies, will be attending the NewYorkBIO Life Science Company Showcase - Aardvark Therapeutics to present; and announces expansion to medical...
Nov 25, 2020
REV.1 Engineering, a leader in the design and development of complex medical devices, examines the current pressures the pandemic is placing on the medical device industry and explores potential strategic contingencies in response.
May 07, 2020
The global pandemic will undoubtably depress equity investments in medical device startups. In response, REV•1 announces a nimble, efficient and accelerated approach to new device development and commercialization.
Jan 14, 2020
World-class medical device design & development firm reformats website to support growing client base.
Sep 18, 2019
Addition of Large Format, HP Multi Jet Fusion 580 Additive Manufacturing Platform Enhances Capabilities.
Jul 26, 2019
Leonhardt Ventures taps REV•1 Engineering to design and develop Valvublator's heart valve regeneration technology platform.
Jan 03, 2019
Ablative Solutions (Kalamazoo, MI) announces major investment in support of their innovative device technology intended for the treatment of hypertension.
Jun 19, 2018
Phil Burke to Present "Best Practices" for Device Development with Drug/Device Combination Products at Boston Summit.
Dec 11, 2017
Celebrating its 10th year anniversary, REV•1 Engineering is expanding to deliver comprehensive, strategic development and innovation solutions for its medical device and life science customers.
Aug 03, 2016
Molekule (San Francisco, CA), developers of the world's first molecular air purifier, announced they have closed on $3.25 million in equity financing from SoftTech VC, Crosslink Capital and CSC Upshot.